ArticleCancer immunology, immunotherapy : CII2024

A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.

Jing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.